Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients

Journal of the American Geriatrics Society

Volumn 44, Issue 5, 1996, Pages 521-523

  Aronow, Wilbert S ^a,b   Ahn, Chul ^c   Gutstein, Hal ^c  

^a American Geriatrics Society   (United States)

^b HEBREW HOSPITAL HOME   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE;

EID: 0029869807     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01436.x     Document Type: Article

References (12)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
2. Aronow WS. Correlation of arrhythmias and conduction defects on the resting electrocardiogram with new cardiac events in 1,153 elderly patients. Am J Noinvasive Cardiol 1991;5:88-90.
3. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
4. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
5. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
6. Peterson P, Kastrup J, Helweg-Larsen S et al. Risk factors for thromboembolic complications in chronic atrial fibrillation. Arch intern Med 1990;150:819-821.
7. Ezekowitz MD, Bridgers SL, James KE et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.
8. Connolly SJ, Laupacis A, Gent M et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:345-355.
9. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
10. Aronow WS, Gutstein H, Hsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 1989;63:366-367.
11. Aronow WS, Koenigsberg M, Kronzon I, Gutstein H. Association of mitral anular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients. Am J Cardiol 1990;65:1511-1512.
12. Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation: Risk marker for stroke (editorial). N Engl J Med 1990;323:1556-1558.